AZ Completes transaction with Acerta Pharma
ASTRAZENECA COMPLETES TRANSACTION FOR MAJORITY EQUITY STAKE INVESTMENT IN ACERTA PHARMA AstraZeneca today announced that it has completed the transaction to acquire a majority equity stake in Acerta Pharma, a privately-owned biopharmaceutical company based in the Netherlands and US. The transaction, announced in December 2015 , provides AstraZeneca with a potential best-in-class irreversible oral Bruton's tyrosine kinase (BTK)